Impact of Protein Glycosylation on Lipoprotein Metabolism and Atherosclerosis.
暂无分享,去创建一个
[1] E. Stroes,et al. Common gene variants in ASGR1 gene locus associate with reduced cardiovascular risk in absence of pleiotropic effects. , 2020, Atherosclerosis.
[2] D. Rader,et al. Novel congenital disorder of O-linked glycosylation caused by GALNT2 loss of function. , 2020, Brain : a journal of neurology.
[3] D. Lefeber,et al. Reduced CETP glycosylation and activity in patients with homozygous B4GALT1 mutations , 2019, Journal of inherited metabolic disease.
[4] L. Al-Gazali,et al. Endoplasmic reticulum quality control of LDLR variants associated with familial hypercholesterolemia , 2019, FEBS open bio.
[5] A. Avan,et al. Scavenger receptor Class B type I as a potential risk stratification biomarker and therapeutic target in cardiovascular disease , 2019, Journal of cellular physiology.
[6] C. Lebrilla,et al. Site-Specific Glycoprofiles of HDL-Associated ApoE are Correlated with HDL Functional Capacity and Unaffected by Short-Term Diet. , 2019, Journal of proteome research.
[7] Richard G. Lee,et al. ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors. , 2019, Arteriosclerosis, thrombosis, and vascular biology.
[8] N. Seidah,et al. Hypolipidaemia among patients with PMM2-CDG is associated with low circulating PCSK9 levels: a case report followed by observational and experimental studies , 2019, Journal of Medical Genetics.
[9] D. Rader,et al. N-Glycosylation Defects in Humans Lower Low-Density Lipoprotein Cholesterol Through Increased Low-Density Lipoprotein Receptor Expression , 2019, Circulation.
[10] G. Norata,et al. Immunometabolic function of cholesterol in cardiovascular disease and beyond. , 2019, Cardiovascular research.
[11] A. Orekhov,et al. Glycosylation of human plasma lipoproteins reveals a high level of diversity, which directly impacts their functional properties. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.
[12] G. Norata,et al. Biological Consequences of Dysfunctional HDL. , 2019, Current medicinal chemistry.
[13] G. Norata,et al. Lysosomal Acid Lipase: From Cellular Lipid Handler to Immunometabolic Target. , 2019, Trends in pharmacological sciences.
[14] K. Linton,et al. Identification of CD36 as a new interaction partner of membrane NEU1: potential implication in the pro-atherogenic effects of the elastin receptor complex , 2018, Cellular and Molecular Life Sciences.
[15] I. Gudelj,et al. Immunoglobulin G glycosylation in aging and diseases. , 2018, Cellular immunology.
[16] A. Fox-Robichaud,et al. Sialidase down-regulation reduces non-HDL cholesterol, inhibits leukocyte transmigration, and attenuates atherosclerosis in ApoE knockout mice , 2018, The Journal of Biological Chemistry.
[17] A. Annoni,et al. Myeloid apolipoprotein E controls dendritic cell antigen presentation and T cell activation , 2018, Nature Communications.
[18] D. Girelli,et al. Sialylated isoforms of apolipoprotein C-III and plasma lipids in subjects with coronary artery disease , 2018, Clinical chemistry and laboratory medicine.
[19] N. Seidah,et al. Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions , 2018, The Journal of Biological Chemistry.
[20] Xian-cheng Jiang,et al. Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis , 2018, Journal of Lipid Research.
[21] Khoa Nguyen,et al. Targeted Measurements of O- and N-Glycopeptides Show That Proteins in High Density Lipoprotein Particles Are Enriched with Specific Glycosylation Compared to Plasma. , 2017, Journal of proteome research.
[22] Honglin Li,et al. Functional Metabolomics Characterizes a Key Role for N-Acetylneuraminic Acid in Coronary Artery Diseases , 2017, Circulation.
[23] D. Rader,et al. New insights into the role of glycosylation in lipoprotein metabolism , 2017, Current opinion in lipidology.
[24] A. Orekhov,et al. Chemical composition of circulating native and desialylated low density lipoprotein: what is the difference? , 2017 .
[25] A. Chabowski,et al. The role of CD36 receptor in the pathogenesis of atherosclerosis. , 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.
[26] A. Zwinderman,et al. Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk: The EPIC-Norfolk Prospective Population Study , 2017, Arteriosclerosis, thrombosis, and vascular biology.
[27] J. Danesh,et al. ANGPTL3 Deficiency and Protection Against Coronary Artery Disease. , 2017, Journal of the American College of Cardiology.
[28] D. Legrand,et al. TMEM165 deficiencies in Congenital Disorders of Glycosylation type II (CDG-II): Clues and evidences for roles of the protein in Golgi functions and ion homeostasis. , 2017, Tissue & cell.
[29] A. Parikh,et al. HDL Glycoprotein Composition and Site-Specific Glycosylation Differentiates Between Clinical Groups and Affects IL-6 Secretion in Lipopolysaccharide-Stimulated Monocytes , 2017, Scientific Reports.
[30] D. Neumann,et al. Post-translational modifications of CD36 (SR-B2): Implications for regulation of myocellular fatty acid uptake. , 2016, Biochimica et biophysica acta.
[31] B. Nordestgaard,et al. Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology , 2016, Journal of Lipid Research.
[32] A. Orekhov,et al. Carbohydrate composition of circulating multiple-modified low-density lipoprotein , 2016, Vascular health and risk management.
[33] Christopher D. Brown,et al. Loss of Function of GALNT2 Lowers High-Density Lipoproteins in Humans, Nonhuman Primates, and Rodents. , 2016, Cell metabolism.
[34] Sumitra Govindarajan,et al. Plasma Myeloperoxidase and Total Sialic Acid as Prognostic Indicators in Acute Coronary Syndrome. , 2016, Journal of clinical and diagnostic research : JCDR.
[35] D. Gudbjartsson,et al. Variant ASGR1 Associated with a Reduced Risk of Coronary Artery Disease. , 2016, The New England journal of medicine.
[36] D. Billheimer,et al. Disialylated apolipoprotein C-III proteoform is associated with improved lipids in prediabetes and type 2 diabetes1[S] , 2016, Journal of Lipid Research.
[37] Dajiang J. Liu,et al. Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease , 2016, Science.
[38] A. Hoischen,et al. TMEM199 Deficiency Is a Disorder of Golgi Homeostasis Characterized by Elevated Aminotransferases, Alkaline Phosphatase, and Cholesterol and Abnormal Glycosylation. , 2016, American journal of human genetics.
[39] A. Hoischen,et al. CCDC115 Deficiency Causes a Disorder of Golgi Homeostasis with Abnormal Protein Glycosylation. , 2016, American journal of human genetics.
[40] M. Goran,et al. The Association of Human Apolipoprotein C-III Sialylation Proteoforms with Plasma Triglycerides , 2015, PloS one.
[41] C. Lebrilla,et al. Combined High-Density Lipoprotein Proteomic and Glycomic Profiles in Patients at Risk for Coronary Artery Disease. , 2015, Journal of proteome research.
[42] G. Norata,et al. Apolipoprotein C-III: From Pathophysiology to Pharmacology. , 2015, Trends in pharmacological sciences.
[43] G. Norata,et al. HDL in infectious diseases and sepsis. , 2015, Handbook of experimental pharmacology.
[44] L. Badimón,et al. Glycoproteome of human apolipoprotein A-I: N- and O-glycosylated forms are increased in patients with acute myocardial infarction. , 2014, Translational research : the journal of laboratory and clinical medicine.
[45] W. Harris,et al. Reduced Apolipoprotein Glycosylation in Patients with the Metabolic Syndrome , 2014, PloS one.
[46] B. Nordestgaard,et al. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. , 2014, The New England journal of medicine.
[47] He Zhang,et al. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. , 2014, The New England journal of medicine.
[48] N. Seidah,et al. Low Density Lipoprotein Receptor Class A Repeats Are O-Glycosylated in Linker Regions* , 2014, The Journal of Biological Chemistry.
[49] M. Bamshad,et al. Solving glycosylation disorders: fundamental approaches reveal complicated pathways. , 2014, American journal of human genetics.
[50] C. Lebrilla,et al. Glycomic Analysis of High Density Lipoprotein Shows a Highly Sialylated Particle , 2014, Journal of proteome research.
[51] J. Jaeken. Glycosylation and its Disorders: General Overview , 2014 .
[52] C. Spahr,et al. Recombinant human lecithin‐cholesterol acyltransferase Fc fusion: Analysis of N‐ and O‐linked glycans and identification and elimination of a xylose‐based O‐linked tetrasaccharide core in the linker region , 2013, Protein science : a publication of the Protein Society.
[53] Fei Zhao,et al. Glycosyltransferase GLT8D2 Positively Regulates ApoB100 Protein Expression in Hepatocytes , 2013, International journal of molecular sciences.
[54] B. Trigatti,et al. Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice , 2012, Journal of Lipid Research.
[55] D. Sahoo,et al. Functional Characterization of Newly-Discovered Mutations in Human SR-BI , 2012, PloS one.
[56] P. Nilsson,et al. Combined effects of brachial pulse pressure and sialic acid for risk of cardiovascular events during 40 years of follow-up in 37 843 individuals , 2012, Journal of hypertension.
[57] Kathryn M. Spitler,et al. O-GlcNAcylation and oxidation of proteins: is signalling in the cardiovascular system becoming sweeter? , 2012, Clinical science.
[58] Kelley W. Moremen,et al. Vertebrate protein glycosylation: diversity, synthesis and function , 2012, Nature Reviews Molecular Cell Biology.
[59] H. Wandall,et al. Probing isoform-specific functions of polypeptide GalNAc-transferases using zinc finger nuclease glycoengineered SimpleCells , 2012, Proceedings of the National Academy of Sciences.
[60] Sander Kersten,et al. Regulation of triglyceride metabolism by Angiopoietin-like proteins. , 2012, Biochimica et biophysica acta.
[61] J. Albers,et al. Role of plasma phospholipid transfer protein in lipid and lipoprotein metabolism. , 2012, Biochimica et biophysica acta.
[62] A. Zwinderman,et al. Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man. , 2011, Cell metabolism.
[63] G. Norata,et al. HDLs, immunity, and atherosclerosis , 2011, Current opinion in lipidology.
[64] H. Kennedy,et al. Impact of site-specific N-glycosylation on cellular secretion, activity and specific activity of the plasma phospholipid transfer protein. , 2011, Biochimica et biophysica acta.
[65] M. Hayden,et al. Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans , 2011, Clinical genetics.
[66] C. Des Rosiers,et al. Acute Regulation of Cardiac Metabolism by the Hexosamine Biosynthesis Pathway and Protein O-GlcNAcylation , 2011, PloS one.
[67] E. Bennett,et al. O-Glycosylation Modulates Proprotein Convertase Activation of Angiopoietin-like Protein 3 , 2010, The Journal of Biological Chemistry.
[68] Tanya M. Teslovich,et al. Biological, Clinical, and Population Relevance of 95 Loci for Blood Lipids , 2010, Nature.
[69] M. Raftery,et al. Glycosylation and Sialylation of Macrophage-derived Human Apolipoprotein E Analyzed by SDS-PAGE and Mass Spectrometry , 2010, Molecular & Cellular Proteomics.
[70] D. Drucker,et al. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. , 2009, Gastroenterology.
[71] K. Linton,et al. The Human Scavenger Receptor CD36 , 2009, The Journal of Biological Chemistry.
[72] R. Collins,et al. Common variants at 30 loci contribute to polygenic dyslipidemia , 2009, Nature Genetics.
[73] M. Goodarzi,et al. Changes in sialylation of low‐density lipoprotein in coronary artery disease , 2008 .
[74] R. Collins,et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease , 2008, Nature Genetics.
[75] Gert Matthijs,et al. Impaired glycosylation and cutis laxa caused by mutations in the vesicular H+-ATPase subunit ATP6V0A2 , 2008, Nature Genetics.
[76] E. Sarandöl,et al. Sialic acid and oxidizability of lipid and proteins and antioxidant status in patients with coronary artery disease , 2007, Cell biochemistry and function.
[77] D. Rader,et al. Hepatic proprotein convertases modulate HDL metabolism. , 2007, Cell metabolism.
[78] Z. Serdar,et al. The relation between oxidant and antioxidant parameters and severity of acute coronary syndromes , 2007, Acta cardiologica.
[79] J. Marth,et al. Glycosylation in Cellular Mechanisms of Health and Disease , 2006, Cell.
[80] S. Qu,et al. N-Glycosylation is Required for Secretion-Competent Human Plasma Phospholipid Transfer Protein , 2006, The protein journal.
[81] T. Hennet,et al. Congenital disorder of glycosylation (CDG) Ig: Report on a patient and review of the literature , 2005, Journal of Inherited Metabolic Disease.
[82] T. Manabe,et al. Direct targeting of human plasma for matrix‐assisted laser desorption/ionization and analysis of plasma proteins by time of flight‐mass spectrometry , 2005, Electrophoresis.
[83] T. Hayakawa,et al. Site-specific glycosylation analysis of human apolipoprotein B100 using LC/ESI MS/MS. , 2005, Glycobiology.
[84] W. Dobyns,et al. Olivopontocerebellar atrophy leading to recognition of carbohydrate-deficient glycoprotein syndrome type I , 1996, Journal of Neurology.
[85] M. Krieger,et al. Identification of the N-Linked Glycosylation Sites on the High Density Lipoprotein (HDL) Receptor SR-BI and Assessment of Their Effects on HDL Binding and Selective Lipid Uptake* , 2003, The Journal of Biological Chemistry.
[86] R. McLeod,et al. The N-linked oligosaccharides at the amino terminus of human apoB are important for the assembly and secretion of VLDL DOI 10.1194/jlr.M200077-JLR200 , 2002, Journal of Lipid Research.
[87] P. Rudd,et al. Structural Elucidation of the N- andO-Glycans of Human Apolipoprotein(a) , 2001, The Journal of Biological Chemistry.
[88] A. Munnich,et al. A broad spectrum of clinical presentations in congenital disorders of glycosylation I: a series of 26 cases , 2001, Journal of medical genetics.
[89] H. Gylling,et al. Sialic acid content of low density lipoprotein and its relation to lipid concentrations and metabolism of low density lipoprotein and cholesterol. , 2000, Journal of lipid research.
[90] T. Mazzone,et al. Transport and Processing of Endogenously Synthesized ApoE on the Macrophage Cell Surface* , 2000, The Journal of Biological Chemistry.
[91] P. Marmillot,et al. Desialylation of human apolipoprotein E decreases its binding to human high-density lipoprotein and its ability to deliver esterified cholesterol to the liver. , 1999, Metabolism: clinical and experimental.
[92] J. Chambers,et al. Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain. , 1999, Atherosclerosis.
[93] J. Kaski,et al. Serum sialic acid concentration is not associated with the extent or severity of coronary artery disease in patients with stable angina pectoris. , 1998, American heart journal.
[94] M. Jauhiainen,et al. Biosynthesis and secretion of human plasma phospholipid transfer protein. , 1998, Journal of lipid research.
[95] N. Davidson,et al. Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro. , 1998, Journal of lipid research.
[96] M. Passarelli,et al. Lipoprotein desialylation simultaneously enhances the cell cholesterol uptake and impairs the reverse cholesterol transport system: in vitro evidences utilizing neuraminidase-treated lipoproteins and mouse peritoneal macrophages. , 1998, Atherosclerosis.
[97] R. Dwek,et al. Concepts and principles of O-linked glycosylation. , 1998, Critical reviews in biochemistry and molecular biology.
[98] K. Adeli,et al. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[99] M. Tremblay,et al. Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions. , 1997, Journal of lipid research.
[100] V. Tertov,et al. Metabolism of native and naturally occurring multiple modified low density lipoprotein in smooth muscle cells of human aortic intima. , 1997, Experimental and molecular pathology.
[101] N. Packer,et al. Desialylated LDL uptake in human and mouse macrophages can be mediated by a lectin receptor. , 1996, Atherosclerosis.
[102] Xavier Collet,et al. Site‐specific detection and structural characterization of the glycosylation of human plasma proteins lecithin:cholesterol acyltransferase and apolipoprotein D using HPLC/electrospray mass spectrometry and sequential glycosidase digestion , 1995, Protein science : a publication of the Protein Society.
[103] R. Hammer,et al. Asialoglycoprotein receptor deficiency in mice lacking the minor receptor subunit. , 1994, The Journal of biological chemistry.
[104] Terri L. Gilbert,et al. Complete cDNA encoding human phospholipid transfer protein from human endothelial cells. , 1994, The Journal of biological chemistry.
[105] F. Paillard,et al. LDL sialic acid content in patients with coronary artery disease. , 1993, Clinica chimica acta; international journal of clinical chemistry.
[106] R. Mcleod,et al. Lecithin:cholesterol acyltransferase: role of N-linked glycosylation in enzyme function. , 1993, The Biochemical journal.
[107] A. Tall,et al. Human plasma cholesteryl ester transfer protein consists of a mixture of two forms reflecting variable glycosylation at asparagine 341. , 1993, Biochemistry.
[108] A. Varki,et al. Biological roles of oligosaccharides: all of the theories are correct , 1993, Glycobiology.
[109] J. Hoeg,et al. O-linked glycosylation modifies the association of apolipoprotein A-II to high density lipoproteins. , 1993, The Journal of biological chemistry.
[110] V. Tertov,et al. Carbohydrate composition of protein and lipid components in sialic acid-rich and -poor low density lipoproteins from subjects with and without coronary artery disease. , 1993, Journal of lipid research.
[111] V. Tertov,et al. Multiple-modified desialylated low density lipoproteins that cause intracellular lipid accumulation. Isolation, fractionation and characterization. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[112] V. Tertov,et al. Sialic acid content of human low density lipoproteins affects their interaction with cell receptors and intracellular lipid accumulation. , 1992, Journal of lipid research.
[113] L. Råstam,et al. Serum Sialic Acid Concentration Predicts both Coronary Heart Disease and Stroke Mortality: Multivariate Analysis Including 54385 Men and Women during 20.5 Years Follow-up , 1992 .
[114] K. Takeshita,et al. The carbohydrate deficient glycoprotein syndrome in three Japanese children , 1992, Brain and Development.
[115] C. Fielding,et al. Effects of inhibitors of N-linked oligosaccharide processing on the secretion, stability, and activity of lecithin:cholesterol acyltransferase. , 1991, Biochemistry.
[116] V. Tertov,et al. Isolation of atherogenic modified (desialylated) low density lipoprotein from blood of atherosclerotic patients: separation from native lipoprotein by affinity chromatography. , 1990, Biochemical and biophysical research communications.
[117] V. Tertov,et al. Modification of low density lipoprotein by desialylation causes lipid accumulation in cultured cells: discovery of desialylated lipoprotein with altered cellular metabolism in the blood of atherosclerotic patients. , 1989, Biochemical and biophysical research communications.
[118] M. Krieger,et al. Expression of ApoE gene in Chinese hamster cells with a reversible defect in O-glycosylation. Glycosylation is not required for apoE secretion. , 1989, The Journal of biological chemistry.
[119] I. Filipović. Effect of inhibiting N-glycosylation on the stability and binding activity of the low density lipoprotein receptor. , 1989, The Journal of biological chemistry.
[120] J. Taylor,et al. Glycosylation of human apolipoprotein E. The carbohydrate attachment site is threonine 194. , 1989, The Journal of biological chemistry.
[121] V. Zannis,et al. Mutagenesis of the glycosylation site of human ApoCIII. O-linked glycosylation is not required for ApoCIII secretion and lipid binding. , 1988, The Journal of biological chemistry.
[122] D. Kingsley,et al. Use of a mutant cell line to study the kinetics and function of O-linked glycosylation of low density lipoprotein receptors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[123] E. Eggermont,et al. AN APPARENT HOMOZYGOUS X-LINKED DISORDER WITH CARBOHYDRATE-DEFICIENT SERUM GLYCOPROTEINS , 1987, The Lancet.
[124] N. Hilschmann,et al. Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions. , 1987, Biological chemistry Hoppe-Seyler.
[125] T. Ogura,et al. Molecular cloning of a human apoC-III variant: Thr 74----Ala 74 mutation prevents O-glycosylation. , 1987, Journal of lipid research.
[126] E. Chen,et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen , 1987, Nature.
[127] M. Kuwano,et al. Low binding capacity and altered O-linked glycosylation of low density lipoprotein receptor in a monensin-resistant mutant of Chinese hamster ovary cells. , 1987, The Journal of biological chemistry.
[128] M. Kuwano,et al. Chinese hamster ovary cell mutant with defective down-regulation of low density lipoprotein receptors. , 1987, The Journal of biological chemistry.
[129] G. Assmann,et al. Characterization of an apolipoprotein C-III mutant by high-performance liquid chromatography and time-of-flight secondary ion mass spectrometry. , 1987, Journal of chromatography.
[130] W. C. Breckenridge,et al. Isolation and partial characterization of apolipoprotein (a) from human lipoprotein (a). , 1986, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[131] A. Scanu,et al. Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a). , 1986, The Journal of biological chemistry.
[132] D. Kingsley,et al. Reversible defects in O-linked glycosylation and LDL receptor expression in a UDP-Gal UDP-GalNAc 4-epimerase deficient mutant , 1986, Cell.
[133] A. Catapano. The distribution of apo C-II and apo C-III in very low density lipoproteins of normal and type IV subjects. , 1980, Atherosclerosis.
[134] N. Takahashi. Demonstration of a new amidase acting on glycopeptides. , 1977, Biochemical and biophysical research communications.
[135] N. Swaminathan,et al. The monosaccharide composition and sequence of the carbohydrate moiety of human serum low density lipoproteins. , 1976, Biochemistry.
[136] A. Tall,et al. Plasma cholesteryl ester transfer protein. , 1993, Journal of lipid research.